Matches in Wikidata for { <http://www.wikidata.org/entity/Q65389589> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q65389589 description "clinical trial" @default.
- Q65389589 description "ensayu clínicu" @default.
- Q65389589 description "klinisch onderzoek" @default.
- Q65389589 description "клінічне випробування" @default.
- Q65389589 description "կլինիկական փորձարկում" @default.
- Q65389589 name "Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients" @default.
- Q65389589 name "Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients" @default.
- Q65389589 type Item @default.
- Q65389589 label "Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients" @default.
- Q65389589 label "Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients" @default.
- Q65389589 prefLabel "Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients" @default.
- Q65389589 prefLabel "Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients" @default.
- Q65389589 P1132 Q65389589-64C6DA8B-A9BB-4377-BFFB-404C5F617FC2 @default.
- Q65389589 P1476 Q65389589-16AAAC9C-6312-4250-87CB-468EEEEEB320 @default.
- Q65389589 P17 Q65389589-2C1C1CB3-AF1D-42F1-A32A-1DDCD92F6062 @default.
- Q65389589 P2899 Q65389589-11AA5952-0015-477A-A516-46A543EC3E67 @default.
- Q65389589 P3098 Q65389589-7B12B9D3-793D-4BA9-A3E8-B606EAD6E06E @default.
- Q65389589 P31 Q65389589-0926501F-4AD0-4AB7-A14A-C2D311D40319 @default.
- Q65389589 P580 Q65389589-545A5752-303F-408D-BB69-FF8E1EA87285 @default.
- Q65389589 P582 Q65389589-765EE8A7-4323-45D5-9D35-6EB274F247AE @default.
- Q65389589 P6099 Q65389589-8AA58BC2-5B41-4A7F-BD6C-83145E0335D0 @default.
- Q65389589 P6153 Q65389589-DBA3A3DB-842E-4A5A-82B2-7025AAC5E6FF @default.
- Q65389589 P767 Q65389589-90CF5DEE-F8E0-419E-93AB-D1C7EE1C7189 @default.
- Q65389589 P8363 Q65389589-9B5DAEB2-D326-473C-8982-0F7A8163FDAE @default.
- Q65389589 P1132 "+69" @default.
- Q65389589 P1476 "Induction Cetuximab (IM-C225), Gemcitabine and Oxaliplatin, Followed by Radiotherapy With Concurrent Capecitabine, and Cetuximab, Followed by Maintenance Cetuximab and Gemcitabine for Patients With Locally Advanced Pancreatic Cancer" @default.
- Q65389589 P17 Q30 @default.
- Q65389589 P2899 "+18" @default.
- Q65389589 P3098 "NCT00338039" @default.
- Q65389589 P31 Q30612 @default.
- Q65389589 P580 "2005-09-01T00:00:00Z" @default.
- Q65389589 P582 "2011-06-01T00:00:00Z" @default.
- Q65389589 P6099 Q42824440 @default.
- Q65389589 P6153 Q7896459 @default.
- Q65389589 P767 Q266423 @default.
- Q65389589 P8363 Q78089383 @default.